GlobalData on MSN
Pilatus Biosciences doses first patient in PLT012 antibody trial
The study will assess the tolerability, safety, maximum tolerated dose, and the recommended Phase II dose of PLT012.
FAS, fatty acid synthase; FATP, fatty acid transporter protein; GPCR, G protein-coupled receptor; LPC, lysophosphatidylcholine; LXR, liver X receptor; PPARγ, peroxisome proliferator-activated receptor ...
Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide and claiming hundreds of thousands of lives each year. A growing body of evidence now ...
Researchers have uncovered how metabolic reprogramming contributes to renal fibrosis in IgG4-related disease (IgG4-RD), a systemic immune-mediated disorder. The review, published in a leading journal, ...
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel mechanisms of the metabolic-immune interaction that ...
Roswell Park Comprehensive Cancer Center postdoctoral researcher Catherine Rono studies how metabolic stress in myeloid cells ...
News-Medical.Net on MSN
Study reveals cellular and metabolic landscape of lymph node metastasis in breast cancer
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast ...
Scientists at City of Hope and the Broad Institute and Keio University have discovered how specific gut bacteria work ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results